Dataset Information


Loss of actomyosin regulation in distal arthrogryposis myopathy due to mutant myosin binding protein-C slow.

ABSTRACT: Myosin binding protein C (MyBP-C) is expressed in striated muscles, where it plays key roles in the modulation of actomyosin cross-bridges. Slow MyBP-C (sMyBP-C) consists of multiple variants sharing common domains but also containing unique segments within the NH2 and COOH termini. Two missense mutations in the NH2 terminus (W236R) and COOH terminus (Y856H) of sMyBP-C have been causally linked to the development of distal arthrogryposis-1 (DA-1), a severe skeletal muscle disorder. Using a combination of in vitro binding and motility assays, we show that the COOH terminus mediates binding of sMyBP-C to thick filaments, while the NH2 terminus modulates the formation of actomyosin cross-bridges in a variant-specific manner. Consistent with this, a recombinant NH2-terminal peptide that excludes residues 34-59 reduces the sliding velocity of actin filaments past myosin heads from 9.0 ± 1.3 to 5.7 ± 1.0 ?m/s at 0.1 ?M, while a recombinant peptide that excludes residues 21-59 fails to do so. Notably, the actomyosin regulatory properties of sMyBP-C are completely abolished by the presence of the DA-1 mutations. In summary, our studies are the first to show that the NH2 and COOH termini of sMyBP-C have distinct functions, which are regulated by differential splicing, and are compromized by the presence of missense point mutations linked to muscle disease.

PROVIDER: S-EPMC3714579 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC3872291 | BioStudies
1993-01-01 | S-EPMC2200114 | BioStudies
| S-EPMC6219831 | BioStudies
| S-EPMC6281772 | BioStudies
| S-EPMC6685440 | BioStudies
| S-EPMC6815179 | BioStudies
| S-EPMC2852610 | BioStudies
| S-EPMC7134574 | BioStudies
| S-EPMC2695803 | BioStudies
| S-EPMC4767423 | BioStudies